$TLF
TANDY LEATHER FACTORY INC

2023 Q3 Form 10-Q Financial Statement

#000114036123039677 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $17.54M $17.48M
YoY Change -7.95% -5.04%
Cost Of Revenue $6.604M $6.561M
YoY Change -11.49% -17.04%
Gross Profit $10.94M $10.92M
YoY Change -5.67% 4.0%
Gross Profit Margin 62.35% 62.47%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $300.0K $300.0K
YoY Change 0.0% 1.69%
% of Gross Profit 2.74% 2.75%
Operating Expenses $10.06M $10.13M
YoY Change -5.27% -9.86%
Operating Profit $880.0K $790.0K
YoY Change -9.84% -207.19%
Interest Expense $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net -$43.00K $2.000K
YoY Change -960.0% -106.67%
Pretax Income $837.0K $792.0K
YoY Change -14.68% -203.26%
Income Tax $201.0K $261.0K
% Of Pretax Income 24.01% 32.95%
Net Earnings $636.0K $531.0K
YoY Change -12.03% -190.15%
Net Earnings / Revenue 3.63% 3.04%
Basic Earnings Per Share $0.08 $0.06
Diluted Earnings Per Share $0.08 $0.06
COMMON SHARES
Basic Shares Outstanding 8.329M 8.301M
Diluted Shares Outstanding 8.405M 8.367M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.620M $10.03M
YoY Change 182.62% 79.49%
Cash & Equivalents $8.623M $10.03M
Short-Term Investments
Other Short-Term Assets $71.00K $68.00K
YoY Change -29.0% -46.03%
Inventory $38.59M $37.51M
Prepaid Expenses $206.0K $375.0K
Receivables $295.0K $421.0K
Other Receivables $390.0K $390.0K
Total Short-Term Assets $48.17M $48.80M
YoY Change -0.29% -0.87%
LONG-TERM ASSETS
Property, Plant & Equipment $10.61M $10.75M
YoY Change -9.12% -7.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $458.0K $456.0K
YoY Change 9.05% 16.03%
Total Long-Term Assets $20.50M $22.13M
YoY Change -6.44% 1.08%
TOTAL ASSETS
Total Short-Term Assets $48.17M $48.80M
Total Long-Term Assets $20.50M $22.13M
Total Assets $68.68M $70.93M
YoY Change -2.21% -0.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.420M $2.340M
YoY Change -71.37% -62.2%
Accrued Expenses $5.870M $5.990M
YoY Change -5.48% 76.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $10.00K
YoY Change
Total Short-Term Liabilities $7.640M $9.043M
YoY Change -31.69% -27.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $326.0K $326.0K
YoY Change -21.82% -21.82%
Total Long-Term Liabilities $326.0K $326.0K
YoY Change -21.82% -21.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.640M $9.043M
Total Long-Term Liabilities $326.0K $326.0K
Total Liabilities $7.966M $9.369M
YoY Change -31.33% -27.02%
SHAREHOLDERS EQUITY
Retained Earnings $61.72M $61.09M
YoY Change 3.83% 4.03%
Common Stock $23.00K $23.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $53.65M $53.00M
YoY Change
Total Liabilities & Shareholders Equity $68.68M $70.93M
YoY Change -2.21% -0.27%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $636.0K $531.0K
YoY Change -12.03% -190.15%
Depreciation, Depletion And Amortization $300.0K $300.0K
YoY Change 0.0% 1.69%
Cash From Operating Activities -$1.130M $1.530M
YoY Change -47.2% -172.86%
INVESTING ACTIVITIES
Capital Expenditures $160.0K $80.00K
YoY Change -57.89% -127.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$160.0K -$80.00K
YoY Change -57.89% -72.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.130M 1.530M
Cash From Investing Activities -160.0K -80.00K
Cash From Financing Activities -20.00K 0.000
Net Change In Cash -1.310M 1.450M
YoY Change -48.02% -131.59%
FREE CASH FLOW
Cash From Operating Activities -$1.130M $1.530M
Capital Expenditures $160.0K $80.00K
Free Cash Flow -$1.290M $1.450M
YoY Change -48.81% -180.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000909724
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
51501000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
340000
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
645000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
65000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
52551000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
225000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1798000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-589000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-253000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
50136000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8327178
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8279108
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8315214
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8426181
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
300000
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
400000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8366904
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8279108
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8329969
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8432897
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
531000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-589000
us-gaap Net Income Loss
NetIncomeLoss
1195000
us-gaap Net Income Loss
NetIncomeLoss
56000
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
4900000

Files In Submission

Name View Source Status
0001140361-23-039677-index-headers.html Edgar Link pending
0001140361-23-039677-index.html Edgar Link pending
0001140361-23-039677.txt Edgar Link pending
0001140361-23-039677-xbrl.zip Edgar Link pending
brhc20057333_10q.htm Edgar Link pending
brhc20057333_ex10-10.htm Edgar Link pending
brhc20057333_ex3-4.htm Edgar Link pending
brhc20057333_ex31-1.htm Edgar Link pending
brhc20057333_ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
image00001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
brhc20057333_10q_htm.xml Edgar Link completed
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlfa-20230630.xsd Edgar Link pending
tlfa-20230630_cal.xml Edgar Link unprocessable
tlfa-20230630_lab.xml Edgar Link unprocessable
tlfa-20230630_def.xml Edgar Link unprocessable
tlfa-20230630_pre.xml Edgar Link unprocessable